Get Free Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=351
The global plasmapheresis market is likely to grow at a steady CAGR of over 7% during the forecast period 2017-2026, and reach a valuation of over US$ 1.5 Bn by the end of 2026. The market is likely to be impacted by a range of macro-economic and micro-economic factors. Increasing emphasis on upgrading healthcare infrastructure, combined with higher awareness on treating thrombotic thrombocytopenic purpura (TTP) and autoimmune diseases are the key factors that will lead to increasing adoption of plasmapheresis as a first line of treatment.
Treatment of the Autoimmune Diseases to Boost Demand
Increasing prevalence of various autoimmune diseases will continue to fuel demand for extracorporeal therapies globally. Occurrence of autoimmune disorders such as lupus can significantly damage various organs such as lungs, kidney, heart, skin and joints. Adoption of plasmapheresis removes putative pathogenic autoantibodies and circulates the immune complexes from the blood of patients with systematic lupus erythematosus. Manufacturers in the healthcare industry are increasingly integrating various technological advancements and innovative features in the plasmapheresis instruments such as apheresis machines in order to offer enhanced instruments for conducting plasmapheresis globally. Bound to these factors, the global plasmapheresis market is expected to witness significant growth during the forecast period.
Research for Biopharmaceutical Applications to Impact Global Market Growth
Demand for plasmapheresis also continues to remain high bound to growing need for donation. Growing need for plasma to treat various disorders such as anaemia, stomach disease, blood loss, cancer, burns, childbirth and heart diseases has led to surge in demand for the donation of the blood products. Moreover, blood products donated are also used for the production of biopharmaceutical medications through the process of fractionation. Biopharmaceutical companies are also increasingly investing in the research and development for production of various medications. Surge in demand for biopharmaceutical medications for the treatment of neuroendocrine tumors, diabetes, cancer and arthritis is further expected to fuel demand for plasmapheresis globally. Moreover, growing need for donating blood products and producing biopharmaceutical products has led to an increasing demand for the plasmapheresis in the global market. Such factors will continue to impact growth of the global plasmapheresis market during positively.
To Get Complete Report with Table of Content, Visit @ https://www.factmr.com/report/351/plasmapheresis-market
Biopharmaceutical Companies to Represent a Leading Segment
Growing need to conduct plasmapheresis has led to surge in demand for various instruments in the global market. On the basis of product type, the instruments segment is expected to represent the highest revenue growth, accounting for a value of over US$ 260 Mn by the end of 2026. However, the disposables product segment is expected to register a robust CAGR during the forecast period.
Based on end users, the biopharmaceutical companies segment is expected to generate significant revenues, recording for a value of over US$ 100 Mn by the end of 2017. In contrary, the other end users segment is expected to register a significant CAGR through 2026.
By application, the source plasma collection segment is expected to witness a robust revenue growth, accounting for a value of nearly US$ 370 Mn by the end of 2026. On the other hand, the centrifugation application segment is expected to register the highest CAGR throughout the forecast period.
Competition Tracking
Leading market players operating in the global plasmapheresis market include Haemonetics Corporation, Asahi Kasei Kuraray Medical, Terumo Corporation, B Braun Melsungen AG, Baxter Internationalaq IncR4T554RFDD., Fresenius SE & Co. KGaA, Kawasumi Laboratories, Inc. and Kaneka Corporation.
Table of Content:
- Global Outlook
- Global Plasmapheresis Market - Executive Summary
- Global Plasmapheresis Market Overview
3.1. Introduction
3.1.1. Global Plasmapheresis Market Taxonomy
3.1.2. Global Plasmapheresis Market Definition
3.2. Global Plasmapheresis Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Plasmapheresis Market Y-o-Y Growth
3.3. Global Plasmapheresis Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. Average Reduction of Plasma Constituents
3.7. Strategic Framework among Key Players of the Plasmapheresis Market
3.8. PESTL Analysis
3.9. Product Lifecycle
3.10. Patents
3.11. List of Distributors
3.12. Approvals
3.13. Key Participants Market Presence (Intensity Map) By Region - Global Plasmapheresis Market Analysis and Forecast 2012-2026
4.1. Global Plasmapheresis Market Size and Forecast By Product Type, 2012-2026
4.1.1. Instruments Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
Continued……………..
Plasmapheresis Market Report is available for Purchase @ https://www.factmr.com/checkout/351/S
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market Insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow Us on Linkedin: https://www.linkedin.com/company/factmr/